Your browser doesn't support javascript.
loading
Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program.
Mazuski, John E; Wagenlehner, Florian; Torres, Antoni; Carmeli, Yehuda; Chow, Joseph W; Wajsbrot, Dalia; Stone, Gregory G; Irani, Paurus; Bharucha, David; Cheng, Karen; Tawadrous, Margaret.
Afiliação
  • Mazuski JE; Department of Surgery, Washington University School of Medicine, St Louis, MO, USA.
  • Wagenlehner F; Department of Urology, Pediatric Urology and Andrology, Justus-Liebig-University, Giessen, Germany.
  • Torres A; Department of Pulmonology, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERES, ICREA, Barcelona, Spain.
  • Carmeli Y; Division of Epidemiology, National Institute for Antibiotic Resistance and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Chow JW; Global Product Development, Pfizer, Collegeville, PA, USA.
  • Wajsbrot D; Biostatistics, Pfizer, New York, NY, USA.
  • Stone GG; Microbiology, Internal Medicine, Pfizer, Groton, CT, USA.
  • Irani P; Global Medical Affairs, Pfizer, Tadworth, Surrey, UK.
  • Bharucha D; Clinical Development, AbbVie, Madison, NJ, USA.
  • Cheng K; Safety Surveillance and Risk Management, Pfizer, Sandwich, Kent, UK.
  • Tawadrous M; Global Product Development, Pfizer, Inc, 445 Eastern Point Road, Groton, CT, 06340, USA. Margaret.Tawadrous@pfizer.com.
Infect Dis Ther ; 10(4): 2399-2414, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34374952
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article